(Q33794089)

English

Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

author name string

Leissinger CA

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5 Suppl 3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

25-32

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Factor VIII inhibitors in mild and moderate-severity haemophilia A.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Inhibitors in hemophilia patients: current status and management

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

A Randomized Study of Factor VIII or Prothrombin Complex Concentrate Infusions in Children with Haemophilia and Antibodies to Factor VIII

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Prothrombin complex concentrates. Use in treatment of hemophiliacs with factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Use of activated prothrombin complex concentrate over multiple surgical episodes in a hemophilic child with an inhibitor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Activated prothrombin concentrate for patients with factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acid

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Myocardial infarction complicating activated prothrombin complex concentrate substitution in patient with hemophilia A.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Magnetic resonance imaging of myocardial infarction during prothrombin complex concentrate therapy of hemophilia A.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Letter: Prothrombin-complex concentrate in treatment of classical haemophilia with factor-VIII antibody

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1999.00034.X

21 January 2018

Identifiers

10.1046/J.1365-2516.1999.00034.X

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33794089&oldid=1956382940"